Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions-Reference-Cited by-同舟云学术

Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions

Published:2021-05-08 Issue:2 Volume:110 Page:392-400
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Létinier Louis¹²³,Jouganous Julien³,Benkebil Mehdi⁴,Bel‐Létoile Alicia³,Goehrs Clément³,Singier Allison¹,Rouby Franck⁵⁶,Lacroix Clémence⁵⁶,Miremont Ghada¹²,Micallef Joëlle⁵⁶,Salvo Francesco¹²,Pariente Antoine¹²

Affiliation:

1. INSERM BPH, U1219 Team Pharmacoepidemiology Univ. Bordeaux Bordeaux France

2. CHU de Bordeaux Pole de Santé Publique Service de Pharmacologie Médicale Centre de Pharmacovigilance de Bordeaux Bordeaux France

3. Synapse Medicine Bordeaux France

4. Surveillance Division Agence nationale de sécurité du médicament et des produits de santé (ANSM) Saint Denis France

5. CRPV Marseille Provence Corse Service Hospitalo‐Universitaire de Pharmacologie Clinique et Pharmacovigilance Assistance Publique Hôpitaux de Marseille Marseille France

6. Institut des Neurosciences des Systèmes INSERM 1106 Aix Marseille Université Marseille France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2266

Reference45 articles.

1. Adoption of electronic health records in UK hospitals: lessons from the USA

2. Semantics-Powered Healthcare Engineering and Data Analytics

3. Policy implications of big data in the health sector

4. Unpatients—why patients should own their medical data

5. Cambridge dictionary. Accessed April 9 2021.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of ensemble learning and data augmentation models for class imbalanced problems: Combination, implementation and evaluation;Expert Systems with Applications;2024-06

2. Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers;Drug Safety;2024-05-08

3. Impact of digital advancements on accounting, auditing and reporting literature: insights, practice implications and future research directions;Journal of Accounting & Organizational Change;2024-04-09

4. An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic;British Journal of Clinical Pharmacology;2024-02-08

5. Regulatory issues of artificial intelligence in cardiology – international perspective;Intelligence-Based Cardiology and Cardiac Surgery;2024